154 related articles for article (PubMed ID: 36562382)
21. Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.
Sarocchi M; Grossi F; Arboscello E; Bellodi A; Genova C; Dal Bello MG; Rijavec E; Barletta G; Rossi G; Biello F; Ghigliotti G; Canepa M; Mussap M; Brunelli C; Spallarossa P
Oncologist; 2018 Aug; 23(8):936-942. PubMed ID: 29567824
[TBL] [Abstract][Full Text] [Related]
22. Frequency of acute coronary syndrome in patients with normal electrocardiogram performed during presence or absence of chest pain.
Turnipseed SD; Trythall WS; Diercks DB; Laurin EG; Kirk JD; Smith DS; Main DN; Amsterdam EA
Acad Emerg Med; 2009 Jun; 16(6):495-9. PubMed ID: 19426294
[TBL] [Abstract][Full Text] [Related]
23. Identifying cancer patients at risk for cardiotoxicity.
Salvatici M; Sandri MT
Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
[TBL] [Abstract][Full Text] [Related]
24. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
Osterlund P; Kinos S; Pfeiffer P; Salminen T; Kwakman JJM; Frödin JE; Shah CH; Sorbye H; Ristamäki R; Halonen P; Soveri LM; Heervä E; Ålgars A; Bärlund M; Hagman H; McDermott R; O'Reilly M; Röckert R; Liposits G; Kallio R; Flygare P; Teske AJ; van Werkhoven E; Punt CJA; Glimelius B
ESMO Open; 2022 Jun; 7(3):100427. PubMed ID: 35798468
[TBL] [Abstract][Full Text] [Related]
25. Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment.
Anaka M; Abdel-Rahman O
Cancer Manag Res; 2022; 14():273-285. PubMed ID: 35115827
[TBL] [Abstract][Full Text] [Related]
26. Circulating Biomarkers for Cardiotoxicity Risk Prediction.
Gong FF; Cascino GJ; Murtagh G; Akhter N
Curr Treat Options Oncol; 2021 Apr; 22(6):46. PubMed ID: 33866434
[TBL] [Abstract][Full Text] [Related]
27. Fluoropyrimidine-Associated Cardiotoxicity.
Kanduri J; More LA; Godishala A; Asnani A
Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of the HEART Pathway and EDACS-ADP when combined with a 0-hour/1-hour hs-cTnT protocol for assessment of acute chest pain patients.
Nilsson T; Johannesson E; Lundager Forberg J; Mokhtari A; Ekelund U
Emerg Med J; 2021 Nov; 38(11):808-813. PubMed ID: 33837120
[TBL] [Abstract][Full Text] [Related]
29. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
Upshaw JN; O'Neill A; Carver JR; Dimond EP; Denlinger CS; Kircher SM; Wagner LI; Ky B; Brell JM
Clin Colorectal Cancer; 2019 Mar; 18(1):44-51. PubMed ID: 30348619
[TBL] [Abstract][Full Text] [Related]
30. Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history.
Kelly C; Bhuva N; Harrison M; Buckley A; Saunders M
Eur J Cancer; 2013 Jul; 49(10):2303-10. PubMed ID: 23583220
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy.
Leger KJ; Leonard D; Nielson D; de Lemos JA; Mammen PP; Winick NJ
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28377429
[TBL] [Abstract][Full Text] [Related]
32. Telemetry-assisted early detection of STEMI in patients with atypical symptoms by paramedic-performed 12-lead ECG with subsequent cardiological analysis.
Campo Dell' Orto M; Hamm C; Liebetrau C; Hempel D; Merbs R; Cuca C; Breitkreutz R
Eur J Emerg Med; 2017 Aug; 24(4):272-276. PubMed ID: 26629763
[TBL] [Abstract][Full Text] [Related]
33. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes.
deFilippi CR; Tocchi M; Parmar RJ; Rosanio S; Abreo G; Potter MA; Runge MS; Uretsky BF
J Am Coll Cardiol; 2000 Jun; 35(7):1827-34. PubMed ID: 10841231
[TBL] [Abstract][Full Text] [Related]
34. Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer.
Castro-Rojas CA; Esparza-Mota AR; Hernandez-Cabrera F; Romero-Diaz VJ; Gonzalez-Guerrero JF; Maldonado-Garza H; Garcia-Gonzalez IS; Buenaventura-Cisneros S; Sanchez-Lopez JY; Ortiz-Lopez R; Camacho-Morales A; Barboza-Quintana O; Rojas-Martinez A
Drug Metab Pers Ther; 2017 Dec; 32(4):209-218. PubMed ID: 29257755
[TBL] [Abstract][Full Text] [Related]
35. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
[TBL] [Abstract][Full Text] [Related]
36. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
37. Assessing sensitivity and specificity of the Manchester Triage System in the evaluation of acute coronary syndrome in adult patients in emergency care: a systematic review protocol.
Nishi FA; de Motta Maia FO; de Lopes Monteiro da Cruz DA
JBI Database System Rev Implement Rep; 2015 Nov; 13(11):64-73. PubMed ID: 26657465
[TBL] [Abstract][Full Text] [Related]
38. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.
Cullen L; Mueller C; Parsonage WA; Wildi K; Greenslade JH; Twerenbold R; Aldous S; Meller B; Tate JR; Reichlin T; Hammett CJ; Zellweger C; Ungerer JPJ; Rubini Gimenez M; Troughton R; Murray K; Brown AFT; Mueller M; George P; Mosimann T; Flaws DF; Reiter M; Lamanna A; Haaf P; Pemberton CJ; Richards AM; Chu K; Reid CM; Peacock WF; Jaffe AS; Florkowski C; Deely JM; Than M
J Am Coll Cardiol; 2013 Oct; 62(14):1242-1249. PubMed ID: 23583250
[TBL] [Abstract][Full Text] [Related]
39. Capecitabine-induced chest pain relieved by diltiazem.
Ambrosy AP; Kunz PL; Fisher GA; Witteles RM
Am J Cardiol; 2012 Dec; 110(11):1623-6. PubMed ID: 22939579
[TBL] [Abstract][Full Text] [Related]
40. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study.
Lenihan DJ; Stevens PL; Massey M; Plana JC; Araujo DM; Fanale MA; Fayad LE; Fisch MJ; Yeh ET
J Card Fail; 2016 Jun; 22(6):433-8. PubMed ID: 27079675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
